Alabama, long renowned for some of the strictest anti-drug laws in the nation, just took a landmark step into the modern era of medical cannabis.
On Jun. 3, a Cullman woman became the first patient in state history to legally purchase medical marijuana at a dispensary, marking a profound shift in a conservative state where possession once carried harsh penalties.
Amanda Taylor, who lives with multiple sclerosis, drove two hours from Cullman to Montgomery on Wednesday to make the historic purchase at Callie’s Apothecary. She described the moment as life-changing, noting that cannabis helps manage her tremors, nausea and other symptoms.
Prior to the historic dispensary visit, Taylor had become a self-described “medical refugee,” temporarily relocating to Arizona for legal access before returning home after Alabama’s 2021 legalisation.
The soft opening of Callie’s Apothecary in Montgomery occurred Wednesday, with the full public opening scheduled for Thursday at 10 a.m. Patients need a valid Alabama medical cannabis card, state ID and physician documents. The program limits products to non-smokable forms like tinctures, oils, patches, tablets and gummies.
The first medical cannabis purchase in Alabama was made this morning at Callie’s Apothecary in Montgomery. It’s been 5 years since the program was created. Amanda Taylor, below, has been an advocate for the medicine in AL for ~11 years. I’ll have a story on this soon. pic.twitter.com/6xJnB7YTj1
— Anna Barrett (@annabjournalist) June 3, 2026
Read more: SNDL’s plan to acquire 27 more dispensaries from 1CM falls through
Road to Alabama budtending was long, winding
Lawmakers approved the Darren Wesley ‘Ato’ Hall Compassion Act in 2021, making Alabama the 37th state to legalise medical cannabis.
Yet legal disputes, lawsuits challenging the licensing process and delays in implementation stalled progress for more than five years. The Alabama Medical Cannabis Commission only issued dispensary licenses to three companies last December, clearing the final major hurdle.
This week’s milestone arrives amid renewed federal momentum. President Trump’s December 2025 executive order directed the Department of Justice to expedite rescheduling marijuana to Schedule III, a move that Acting Attorney General Todd Blanche advanced in April.
The action eases certain restrictions on state-licensed medical programs and signals a more permissive federal stance, potentially reducing banking and tax hurdles for Alabama’s emerging industry even as recreational use remains prohibited federally.
Industry interest and potential contenders
Cannabis companies have watched Alabama closely as the program finally launches. While the state’s tightly regulated market with limited licenses favours local operators, larger players may be eyeing expansion opportunities.
Multistate operators like Curaleaf Holdings Inc (TSE: CURA) (OTCMKTS: CURLF), Green Thumb Industries Inc (CNSX: GTII) (OTCMKTS: GTBIF) (FRA: R9U2) and Trulieve Cannabis Corp (OTCMKTS: TCNNF) (CNSX: TRUL) rank among the most likely prospects for entry if the market matures and additional opportunities arise.
For now, local licensees such as Callie’s Apothecary lead the charge. Patients and advocates are celebrating the breakthrough while acknowledging that more work lies ahead to expand access, certify more physicians and open more medical pot shops across the state.
Read more: Curaleaf scoops trio of accolades at Business of Cannabis Awards
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com
